Aehr Test Systems (AEHR) Tops Q1 EPS by 2c; Offers FY23 Revenue Guidance
Get Alerts AEHR Hot Sheet
Price: $86.26 +13.10%
EPS Growth %: -800.0%
Financial Fact:
Selling, general and administrative: 1.72M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -800.0%
Financial Fact:
Selling, general and administrative: 1.72M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Aehr Test Systems (NASDAQ: AEHR) reported Q1 EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $17.2 million versus the consensus estimate of $16.04 million.
GUIDANCE:
Aehr Test Systems sees FY2023 revenue of $60-70 million, versus the consensus of $65 million.
For earnings history and earnings-related data on Aehr Test Systems (AEHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
- Oxford Industries (OXM) Tops Q2 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share